Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Stem Cell Therapeutics
 More »

  • SCT Licenses Worldwide Rights to Prostate Cancer Stem Cell Assets
    Stem Cell Therapeutics (SCT) said today it entered into an option agreement to exclusively license worldwide rights to a series of prostate cancer stem cell assets from the UK's ...
    8-9-2013
  • Cytori Taps Medistem Technology for Autoimmune Disease Drug Developmen...
    San Diego, CA-based Cytori Therapeutics is using Medistem's patented "Stem Cell Mediated Treg Activation" technology to develop autoimmune disease treatments. Under the terms of ...
    7-19-2013
  • Biogen Idec, University of Edinburgh Team Up for Neurodegenerative...
    in translational medicine, as well as in neuroscience, stem cell research, and regeneration. ... Idec also has a license from Acorda Therapeutics to develop and commercialize outside ...
    7-19-2013
  • Nile Therapeutics to Acquire Capricor
    hospital discharge from acute episodes of heart failure, while continuing the acquired company's development of cardiac stem cell therapeutics to repair damaged heart muscle. ...
    7-8-2013
  • Gene Editing to Treat Genetic Diseases, Part II
    ... Q. Ding and colleagues in the department of stem cell and regenerative biology, Harvard University, reported differentiation of stem cells-both the targeted lines and isogenic ...
    6-20-2013
  • A First: hESCs Generated from Somatic Cells
    Reprogramming somatic cells into pluripotent embryonic stem cells (ESCs) by way of somatic cell nuclear ... the best cell for future therapeutics applications," he said. ...
    5-14-2013
  • Companion Diagnostics: 52 Pick-Up
    ... to cancer therapeutics, targeting the Notch, Wnt, and other pathways critical to the spread of cancer stem cells. ... Roche (Ventana Medical Systems), Pfizer, and Cell Signaling ...
    5-9-2013
  • The Tumor Microenvironment as a Drug Target, Part II
    ... (EGFR) on the cell surface as well as Akt signaling. ... challenge of developing therapeutics to target cancer ... recruitment of mesenchymal stem cells and inflammatory ...
    5-7-2013
  • Human iPSC-Derived Hepatocytes
    from induced pluripotent stem cells (iPSCs). iCell® ... in culture over existing cell lines and primary cells. ... focusing on safer and more in vivo-stable therapeutics. ...
    5-1-2013
  • Biosimilars: 10 Drugs to Watch
    ... studies as of 2012 BioXpress Therapeutics: Biosimilar in active development ... September 2008 for cancer, hematopoietic stem cell transplantation, and neutropenia Dr. ...
    4-22-2013
  • Exploring GPCRs as Therapeutic Targets
    ... Int vitro models, such as inducible pluripotent stem cells, ... antagonist. [Heptares Therapeutics] Heptares Therapeutics ... result being that they can be purified from cell membranes. ...
    4-15-2013
  • Stockholm-Uppsala Region Ups the Ante
    ... firm focused on cancer therapeutics, and BioLamina. ... The company offers a range of laminin cell culture products that, it says, help users to culture both stem cells and ...
    4-15-2013
  • Single-Use Bioreactor Roundup
    ... We are now seeing the beginning of stem cell manufacturing, and we believe this field (and ... development of a new generation of therapeutics, the single-use bioreactor will be ...
    4-15-2013
  • Exosome Research Publication Landscape
    communication, immunological responses, stem cell behavior, cancer cell communication, etc. ... However, the potential clinical application of exosomes in diagnostics and therapeutics ...
    4-15-2013
  • People in the News
    Klingemann is a member of the board for Osiris Therapeutics. Previously, he was professor of medicine and director, bone marrow and stem cell transplant program at Tufts Medical ...
    4-15-2013
  • More »

    Journal Articles

  • Rejuvenation of aging hearts
    Andrew R Mendelsohn, James Larrick
    Rejuvenation Research
    maintain homeostasis and cell differentiation may play ... neurons and hematopoetic stem cells may be caused by ... prospects for the development of anti-aging therapeutics. ...
  • Review: Gene- and Stem Cell-Based Therapeutics for Bone Regeneration...
    Nadav Kimelman, Gadi Pelled, Gregory A. Helm, J. Huard, Edward M. Schwarz, Dan Gazit
    Tissue Engineering, Part A
    Review: Gene- and Stem Cell-Based Therapeutics for Bone Regeneration and Repair Tissue Engineering, Part A
  • Stem Cell Therapeutics: Hope for Patients and Biopharma!
    Ralf Huss
    Stem Cells and Development
    Stem Cell Therapeutics: Hope for Patients and Biopharma! Stem Cells and Development
  • Mesenchymal Stem Cells Home to Sites of Injury and Inflammation
    Kristine C. Rustad, Geoffrey C. Gurtner
    Advances in Wound Care
    Advances in Wound Care Background: Mesenchymal stem cells ... However, the translation of MSC-based therapeutics to ... to monitor stem cell behavior post-transplantation. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll